NL8203456A - Farmaceutische preparaten. - Google Patents

Farmaceutische preparaten. Download PDF

Info

Publication number
NL8203456A
NL8203456A NL8203456A NL8203456A NL8203456A NL 8203456 A NL8203456 A NL 8203456A NL 8203456 A NL8203456 A NL 8203456A NL 8203456 A NL8203456 A NL 8203456A NL 8203456 A NL8203456 A NL 8203456A
Authority
NL
Netherlands
Prior art keywords
triazole
methyl
phenoxy
amino
methanol
Prior art date
Application number
NL8203456A
Other languages
English (en)
Dutch (nl)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8203456A publication Critical patent/NL8203456A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8203456A 1981-09-04 1982-09-03 Farmaceutische preparaten. NL8203456A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8126787 1981-09-04
GB8126787 1981-09-04

Publications (1)

Publication Number Publication Date
NL8203456A true NL8203456A (nl) 1983-04-05

Family

ID=10524317

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203456A NL8203456A (nl) 1981-09-04 1982-09-03 Farmaceutische preparaten.

Country Status (18)

Country Link
JP (1) JPS5855421A (fr)
KR (1) KR840001276A (fr)
AU (1) AU8799882A (fr)
BE (1) BE894286A (fr)
DE (1) DE3232831A1 (fr)
DK (1) DK396582A (fr)
FI (1) FI823041L (fr)
FR (1) FR2512343A1 (fr)
GB (1) GB2105588B (fr)
GR (1) GR76433B (fr)
IL (1) IL66709A0 (fr)
IT (1) IT8249072A0 (fr)
LU (1) LU84364A1 (fr)
NL (1) NL8203456A (fr)
PT (1) PT75504A (fr)
SE (1) SE8205035L (fr)
ZA (1) ZA826479B (fr)
ZW (1) ZW18582A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
GB8805268D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US20110301116A1 (en) * 2008-12-04 2011-12-08 The University Of Tokyo Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ193009A (en) * 1979-03-02 1983-07-15 Glaxo Group Ltd 3-n-(( -aminoalkyl)(furyl thiophenyl or phenyl)(alkyl))-amino-1h-1,2,4-triazoles
GB2063874B (en) * 1979-10-22 1983-09-28 Glaxo Group Ltd Triazole derivatives processes for the preparation thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI823041L (fi) 1983-03-05
ZA826479B (en) 1984-04-25
DE3232831A1 (de) 1983-03-24
SE8205035D0 (sv) 1982-09-03
LU84364A1 (fr) 1984-04-24
FR2512343A1 (fr) 1983-03-11
FI823041A0 (fi) 1982-09-03
JPS5855421A (ja) 1983-04-01
IL66709A0 (en) 1982-12-31
GB2105588B (en) 1984-07-18
GB2105588A (en) 1983-03-30
IT8249072A0 (it) 1982-09-03
PT75504A (en) 1982-10-01
GR76433B (fr) 1984-08-10
KR840001276A (ko) 1984-04-30
AU8799882A (en) 1983-03-10
ZW18582A1 (en) 1984-03-28
BE894286A (fr) 1983-03-02
SE8205035L (sv) 1983-03-05
DK396582A (da) 1983-03-05

Similar Documents

Publication Publication Date Title
KR100202042B1 (ko) 수마트립탄 함유 조성물
GB2105193A (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
EP0969835A1 (fr) Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour reguler l'appetance
JP2002511102A (ja) ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物
JPH0681733B2 (ja) 医薬組成物
US20110086074A1 (en) Combinations of niacin and an oxicam
US5466436A (en) Medicaments for treating inflammatory conditions or for analgesia
CA2232191A1 (fr) Inhibition du facteur alpha de necrose tumorale
KR890003376A (ko) Dhp 축적질 제제물
DE69425589T2 (de) Kombiniertes antipyretisches und analgetisches arzneimittel
JP2004518734A (ja) カルベジロールの新規処方
PL181215B1 (pl) Kompozycja farmaceutyczna zawierająca ibuprofen i kodeinę oraz sposób jej wytwarzania
US5330982A (en) Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
NL8203456A (nl) Farmaceutische preparaten.
US20050203115A1 (en) Narcotic-NSAID ion pairs
JPS6191124A (ja) 抗炎症組成物
US5021448A (en) Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
CA1307739C (fr) Compositions anti-inflammatoires
JPS63246337A (ja) 医薬
US4154833A (en) Antiphlogistic pharmaceutical composition and method of use
NL8900525A (nl) Geneesmiddelen die sufotidine bevatten alsmede de toepassing daarvan.
EP1749525A1 (fr) Combination de pyrazoline substitués et de médicaments contre la dépendance
JPS5925765B2 (ja) 消化性潰瘍治療剤
JPS5865215A (ja) 医薬組成物
NZ193239A (en) Anti-inflammatory compositions containing 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid and a 2-hydroxy-5-halophenylbenzoic acid derivative

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed